Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Lower-Risk
.
Show all posts
Showing posts with label
Lower-Risk
.
Show all posts
Monday, September 30, 2024
FDA Approves Rytelo (imetelstat) for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia
›
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer...
›
Home
View web version
